Hospital Virgen de los Lirios Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Alcoy Spain

Organization Overview

First Clinical Trial
2007
NCT00906061
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

anastrozole (arimidex) (1 trial)

fulvestrant (faslodex) (1 trial)

Drugs in Phase 2 Trials (3)

docetaxel (taxotere) (3 trials)

erlotinib (tarceva) (1 trial)

gemcitabine (gemzar) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Lung Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 5